CN101584763B - Medicinal composition for treating chronic cystitis and preparation method thereof - Google Patents
Medicinal composition for treating chronic cystitis and preparation method thereof Download PDFInfo
- Publication number
- CN101584763B CN101584763B CN 200810112116 CN200810112116A CN101584763B CN 101584763 B CN101584763 B CN 101584763B CN 200810112116 CN200810112116 CN 200810112116 CN 200810112116 A CN200810112116 A CN 200810112116A CN 101584763 B CN101584763 B CN 101584763B
- Authority
- CN
- China
- Prior art keywords
- weight portion
- pharmaceutical composition
- preparation
- composition
- dosage form
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Abstract
The invention discloses a medicinal composition for treating chronic cystitis and a preparation method thereof. The composition consists of red yeast rice, corktree bark and red bean. The preparation method for the medicinal composition prepares a clinically acceptable dosage form by adding conventional accessories according to the conventional process. The medicinal composition has remarkable effect on treating the chronic cystitis and has no side effect.
Description
Technical field
The present invention relates to a kind of pharmaceutical composition, particularly relate to a kind of pharmaceutical composition of treating chronic cystitis.
Background technology
Chronic cystitis is the modal disease of urinary system, sees with the women especially more.Primary disease is not as an independently disease appearance in most of cases, but the part of urinary system infection or the secondary infection of other disease of urinary system.The inflammation of bladder can be divided into acute and chronic two kinds, and both can transform mutually again, and acute chronic cystitis can not get thorough treatment and can delay into chronicly, and chronic cystitis reduces or local patholoic change factor when increasing the weight of at Abwehrkraft des Koepers, can change into acute attack again.The chronic cystitis symptom is similar with acute chronic cystitis, but degree is lighter, is characterized in morbidity " slowly ", inflammatory reaction " gently ", diseased region " deeply ".
Summary of the invention
The object of the invention is to provide a kind of pharmaceutical composition of treating chronic cystitis and preparation method thereof.
Another purpose of the present invention is to provide the new purposes of this pharmaceutical composition.
The present invention realizes through following technical scheme:
The crude drug of pharmaceutical composition of the present invention consists of:
Monas cuspurpureus Went 1-5 weight portion Cortex Phellodendri 3-8 weight portion Semen Phaseoli 1-5 weight portion
The crude drug composition of pharmaceutical composition of the present invention is preferably:
Monas cuspurpureus Went 3 weight portion Cortex Phellodendris 5 weight portion Semen Phaseolis 3 weight portions
The crude drug composition of pharmaceutical composition of the present invention is preferably:
Monas cuspurpureus Went 2 weight portion Cortex Phellodendris 4 weight portion Semen Phaseolis 4 weight portions
The crude drug composition of pharmaceutical composition of the present invention is preferably:
Monas cuspurpureus Went 4 weight portion Cortex Phellodendris 7 weight portion Semen Phaseolis 2 weight portions
Pharmaceutical composition of the present invention adds conventional adjuvant, according to common process, processes the dosage form of clinical acceptance.Said dosage form is tablet, capsule, powder, soft capsule, drop pill, honeyed pill, pill, granule, soft extract with bee honey agent, slow releasing preparation, quick releasing formulation, controlled release preparation, oral liquid, lyophilized injectable powder or ejection preparation.
Medicine composite for curing chronic cystitis effect of the present invention significantly and have no side effect.
Following experimental example and embodiment are used to further specify but are not limited to the present invention.
Experimental example: pharmaceutical composition of the present invention reaches more than 93% through clinical treatment 30 routine chronic cystitis patient's total effective rates, and chronic cystitis case diagnosis standard and criterion of therapeutical effect are pressed the Ministry of Public Health standard and confirmed, 25 routine produce effects wherein, 3 examples effectively, 2 examples are invalid.See the following form
| Criterion of therapeutical effect | Produce effects (routine number) | Effectively (routine number) | Invalid (routine number) |
| 30 examples | 25 examples | 3 examples | 2 examples |
| Effective percentage | 83％ | 10％ | 7％ |
Following embodiment all can realize the effect of above-mentioned experimental example.
The specific embodiment
Embodiment 1:
Monas cuspurpureus Went 3kg Cortex Phellodendri 5kg Semen Phaseoli 3kg
Said medicine adds conventional adjuvant according to common process and processes capsule.
Embodiment 2:
Monas cuspurpureus Went 2kg Cortex Phellodendri 4kg Semen Phaseoli 4kg
Said medicine adds conventional adjuvant according to common process and processes oral liquid.
Embodiment 3:
Monas cuspurpureus Went 4kg Cortex Phellodendri 7kg Semen Phaseoli 2kg
Said medicine adds conventional adjuvant according to common process and processes slow releasing tablet.
Embodiment 4:
Monas cuspurpureus Went 2kg Cortex Phellodendri 7kg Semen Phaseoli 4kg
Said medicine adds conventional adjuvant according to common process and processes lyophilized injectable powder.
Embodiment 5:
Monas cuspurpureus Went 4kg Cortex Phellodendri 8kg Semen Phaseoli 2kg
Said medicine adds conventional adjuvant according to common process and processes injection.
Claims (10)
1. pharmaceutical composition of treating chronic cystitis is characterized in that the crude drug of said composition consists of:
Monas cuspurpureus Went 1-5 weight portion Cortex Phellodendri 3-8 weight portion Semen Phaseoli 1-5 weight portion.
2. pharmaceutical composition as claimed in claim 1 is characterized in that the crude drug of said composition consists of:
Monas cuspurpureus Went 3 weight portion Cortex Phellodendris 5 weight portion Semen Phaseolis 3 weight portions.
3. pharmaceutical composition as claimed in claim 1 is characterized in that the crude drug of said composition consists of:
Monas cuspurpureus Went 2 weight portion Cortex Phellodendris 4 weight portion Semen Phaseolis 4 weight portions.
4. pharmaceutical composition as claimed in claim 1 is characterized in that the crude drug of said composition consists of:
Monas cuspurpureus Went 4 weight portion Cortex Phellodendris 7 weight portion Semen Phaseolis 2 weight portions.
5. like the described pharmaceutical composition of one of claim 1-4, it is characterized in that said composition adds conventional adjuvant,, process the dosage form of clinical acceptance according to common process.
6. pharmaceutical composition as claimed in claim 5 is characterized in that said dosage form is tablet, capsule, powder, pill, granule, soft extract with bee honey agent, slow releasing preparation, quick releasing formulation, controlled release preparation, oral liquid or ejection preparation.
7. pharmaceutical composition as claimed in claim 6 is characterized in that said capsule is a soft capsule, and pill is drop pill or honeyed pill, and ejection preparation is a lyophilized injectable powder.
8. preparation of drug combination method as claimed in claim 5, it is characterized in that this method is: said composition adds conventional adjuvant, according to common process, processes the dosage form of clinical acceptance.
9. like claim 6,7 described preparation of drug combination methods, it is characterized in that this method is: said composition adds conventional adjuvant, according to common process, processes the dosage form of clinical acceptance.
10. like the application of the described pharmaceutical composition of one of claim 1-4 in the medicine of preparation treatment chronic cystitis.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200810112116 CN101584763B (en) | 2008-05-21 | 2008-05-21 | Medicinal composition for treating chronic cystitis and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200810112116 CN101584763B (en) | 2008-05-21 | 2008-05-21 | Medicinal composition for treating chronic cystitis and preparation method thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101584763A CN101584763A (en) | 2009-11-25 |
| CN101584763B true CN101584763B (en) | 2012-07-18 |
Family
ID=41369332
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 200810112116 Active CN101584763B (en) | 2008-05-21 | 2008-05-21 | Medicinal composition for treating chronic cystitis and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101584763B (en) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1541684A (en) * | 2003-11-07 | 2004-11-03 | 曹斌豫 | Oral Chinese traditional medicine preparation for treating cystitis |
| CN101032586A (en) * | 2007-04-04 | 2007-09-12 | 侯雪云 | Chinese traditional medicine composition to be taken orally for curing acute cystitis |
| CN101104044A (en) * | 2007-06-14 | 2008-01-16 | 张红梅 | Traditional Chinese medicine formula for treating urinary infection |
-
2008
- 2008-05-21 CN CN 200810112116 patent/CN101584763B/en active Active
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1541684A (en) * | 2003-11-07 | 2004-11-03 | 曹斌豫 | Oral Chinese traditional medicine preparation for treating cystitis |
| CN101032586A (en) * | 2007-04-04 | 2007-09-12 | 侯雪云 | Chinese traditional medicine composition to be taken orally for curing acute cystitis |
| CN101104044A (en) * | 2007-06-14 | 2008-01-16 | 张红梅 | Traditional Chinese medicine formula for treating urinary infection |
Non-Patent Citations (2)
| Title |
|---|
| 刘先夺等.硫酸妥布霉素膀胱灌注治疗女性慢性膀胱炎132例.《中国药业》.2001,第10卷(第8期),第34页. * |
| 王丽君等.环丙沙星治疗慢性膀胱炎的疗效规察.《北京军区医药》.1994,第6卷(第1期),第7页. * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101584763A (en) | 2009-11-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103223020A (en) | Medicine for treating viral cold and preparation method thereof | |
| CN103055260A (en) | Traditional Chinese medicine composition for treating ulcerative colitis and preparation method thereof | |
| CN104147388B (en) | Traditional Chinese medicine composition for treating migraine and preparation method thereof | |
| CN101584763B (en) | Medicinal composition for treating chronic cystitis and preparation method thereof | |
| CN101411744B (en) | Medicament for treating neoplastic disease | |
| CN102488784A (en) | Traditional Chinese medicine composition for treating low back pain | |
| CN101480412A (en) | Honeybee four-treasure for treating prostatosis | |
| CN101584765B (en) | Pharmaceutical composition for treating chronic cystitis | |
| CN102743707B (en) | Pill for treating acute lumbar sprain | |
| CN102430113A (en) | Compound propolis composition for treating porcine pseudorabies and preparation method thereof | |
| CN102552511B (en) | Medicament for treating diarrhea | |
| CN102397533B (en) | Compound propolis composition for treating livestock egg drop syndrome and preparation method thereof | |
| CN107496558B (en) | Composition for treating cough and application thereof | |
| CN101579379B (en) | Medicinal composition for treating senile dementia and preparation method thereof | |
| CN101579389B (en) | Medicinal composition for treating osteoporosis | |
| CN104784482A (en) | Traditional Chinese medicine for treating chronic pyogenic osteomyelitis | |
| CN101579412B (en) | Medicinal composition for treating prostatauxe and preparation method thereof | |
| CN101579387B (en) | Medicinal composition for treating anorexia nervosa and preparation method thereof | |
| CN101579369B (en) | Medicinal composition for treating rickets and preparation method thereof | |
| CN100562330C (en) | A kind of Chinese powder medicine of analgetic, hemostatic repercussive and sore-arresting functions and compound method thereof | |
| CN101579382B (en) | Medicinal composition for treating diabetes mellitus and preparation method thereof | |
| CN104208577A (en) | Drug for treating gastric ulcers | |
| CN101293004B (en) | Medicament for treating chyluria | |
| CN104095959A (en) | Traditional Chinese medicine for treating diffuse interstitial granulomatous lung diseases | |
| CN110772540A (en) | External plaster for treating tenosynovitis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant |